$36.51
0.41% yesterday
Nasdaq, Nov 28, 07:00 pm CET

Omnicell, Inc. Stock price

$36.66
+6.12 20.04% 1M
+8.43 29.86% 6M
-7.86 17.66% YTD
-8.79 19.34% 1Y
-11.97 24.61% 3Y
-70.13 65.67% 5Y
+6.90 23.19% 10Y
+27.03 280.69% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
-0.34 0.92%

Key metrics

Basic
Market capitalization
$1.6b
Enterprise Value
$1.6b
Net debt
positive
Cash
$205.3m
Shares outstanding
44.9m
Valuation (TTM | estimate)
P/E
87.3 | 21.6
P/S
1.4 | 1.4
EV/Sales
1.4 | 1.3
EV/FCF
17.1
P/B
1.4
Financial Health
Equity Ratio
58.6%
Return on Equity
1.0%
ROCE
1.2%
ROIC
0.7%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$1.2b | $1.2b
EBITDA
$90.8m | $136.6m
EBIT
$17.1m | $78.8m
Net Income
$19.9m | $76.1m
Free Cash Flow
$93.8m
Growth (TTM | estimate)
Revenue
10.7% | 7.9%
EBITDA
34.1% | 55.8%
EBIT
179.5% | 1,334.5%
Net Income
212.6% | 506.9%
Free Cash Flow
-20.7%
Margin (TTM | estimate)
Gross
43.8%
EBITDA
7.7% | 11.4%
EBIT
1.5%
Net
1.7% | 6.3%
Free Cash Flow
8.0%
More
EPS
$0.4
FCF per Share
$2.1
Short interest
7.1%
Employees
4k
Rev per Employee
$300.0k
Show more

Is Omnicell, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Omnicell, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Omnicell, Inc. forecast:

10x Buy
71%
4x Hold
29%

Analyst Opinions

14 Analysts have issued a Omnicell, Inc. forecast:

Buy
71%
Hold
29%

Financial data from Omnicell, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,178 1,178
11% 11%
100%
- Direct Costs 662 662
6% 6%
56%
516 516
17% 17%
44%
- Selling and Administrative Expenses 406 406
8% 8%
34%
- Research and Development Expense 92 92
5% 5%
8%
91 91
34% 34%
8%
- Depreciation and Amortization 74 74
17% 17%
6%
EBIT (Operating Income) EBIT 17 17
180% 180%
1%
Net Profit 20 20
213% 213%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Omnicell, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Omnicell, Inc. Stock News

Neutral
Business Wire
8 days ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference.
Neutral
Business Wire
15 days ago
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies.
Positive
The Motley Fool
29 days ago
It scored not one, but two beats on analyst estimates for its third-quarter performance. This, despite a slight year-over-year decline in adjusted profitability.
More Omnicell, Inc. News

Company Profile

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.

Head office United States
CEO Randall Lipps
Employees 3,670
Founded 1992
Website www.omnicell.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today